Recent Articles from Stocktwits
StockTwits, founded in 2008 by Howard Lindzon and Soren Macbeth, is a leading social media platform designed specifically for investors and traders to share real-time market insights, ideas, and strategies. Headquartered in New York City, the company pioneered the use of "cashtags" (e.g., $AAPL) to organize financial discussions, initially integrating with Twitter before evolving into a standalone network.
Website: https://www.stocktwits.com
Dan Ives, managing director at Wedbush Securities, said in an interview with CNBC, that Nvidia’s chips are fueling the AI revolution.
Via Stocktwits · February 25, 2026
United Therapeutics unveiled a new product called Tresmi, which is “a proprietary drug device formulation of treprostinil into a soft mist inhaler.”
Via Stocktwits · February 25, 2026
If Netflix is allowed to complete its purchase of Warner Brothers, removing competitors and restricting access to essential content libraries could create a monopoly, as per the several state attorneys general.
Via Stocktwits · February 25, 2026
The San Francisco-based AI startup announced 10 new capabilities for enterprise customers to use its technology across functions such as coding, cybersecurity, human resources, and investment banking, among others.
Via Stocktwits · February 25, 2026
The company signed a securities purchase agreement with American Ventures on Tuesday as part of a private placement worth up to $31.3 million.
Via Stocktwits · February 25, 2026
Oddity Tech said that it expected a decline of about 30% in revenues for Q1 2026, with a further drop anticipated in Q2.
Via Stocktwits · February 25, 2026
The site is expected to boost research and engineering efforts tied to SoundHound’s evolving AI agent ecosystem.
Via Stocktwits · February 25, 2026
Longeveron said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo.
Via Stocktwits · February 25, 2026
The company said the equity investment from global institutional investors is expected to strengthen its position in higher-margin programs, including Golden Dome initiatives and NASA-related contracts.
Via Stocktwits · February 25, 2026
CASI stated the Nasdaq determined that the company had failed to satisfy the continued listing conditions to remain listed on the Nasdaq Stock Market.
Via Stocktwits · February 25, 2026
Coinbase Global Inc. and Charter Communications Inc. were among the other large-cap equities that were notably shorted.
Via Stocktwits · February 25, 2026
The company’s board approved a 1-for-30 reverse stock split, effective on February 26.
Via Stocktwits · February 25, 2026
The company stated that, following the withdrawal of Gilgamesh’s challenge, there are no remaining challenges against its patent.
Via Stocktwits · February 25, 2026
The company announced the first shipment of its Intelligent Fingerprinting Drug Screening Readers, produced in collaboration with Syrma Johari MedTech.
Via Stocktwits · February 25, 2026
The company outlined several multi-year financial goals, including expansion of EBITDA margins to the mid-30% range by 2030.
Via Stocktwits · February 25, 2026
Circle beat earnings estimates and saw its stock jump over 15% pre-market after reporting a strong Q4.
Via Stocktwits · February 25, 2026
Analysts expect Nvidia to report a 68% YoY rise in Q4 revenue to $66.12 billion, and an 80% YoY increase in earnings per share to $1.53, according to Fiscal AI data.
Via Stocktwits · February 25, 2026
The company has agreed to develop a cloud-native, secure voice communications platform in partnership with Amazon Web Services.
Via Stocktwits · February 25, 2026
Novo Nordisk will lead global development, regulatory approval, manufacturing, and commercialization of the resulting products.
Via Stocktwits · February 25, 2026
Total revenue reached $48 million for the fourth-quarter with a loss per share (EPS) of $0.05, with both metrics coming in below street estimates.
Via Stocktwits · February 25, 2026
Hedgeye CEO Keith McCullough identified potential Bitcoin support near $62,400 and warned of downside risk toward $54,000.
Via Stocktwits · February 25, 2026
Analyst Brian Essex reduced his price target to $472 from $582 while reiterating an ‘Overweight’ rating.
Via Stocktwits · February 25, 2026
The company noted that if the FDA approves its application, Imosidolimab could address a significant unmet medical need in this rare and life-threatening disorder.
Via Stocktwits · February 25, 2026
The Bitcoin miner swung from profit last year to a $302 million net loss as crypto volatility pressured results.
Via Stocktwits · February 25, 2026
The company reported a 66% decline in Q4 revenue to $41.3 million, which fell short of Street expectations.
Via Stocktwits · February 25, 2026
Recursion reported a loss of $0.21 per share on revenue of $35.5 million, compared to Wall Street estimates of a loss of $0.32 per share on revenue of $24.6 million, according to Koyfin.
Via Stocktwits · February 25, 2026
In a recent interview, Strategy’s executive chairman said that most retail investors would choose a bank account with stable 10% returns over Bitcoin.
Via Stocktwits · February 25, 2026
Zimbabwean Mines Minister Polite Kambamura said that the export ban is effective immediately until further notice.
Via Stocktwits · February 25, 2026
KeyBanc downgraded Evolent Health to ‘Sector Weight’ from ‘Overweight’, citing a lack of visibility in near-term EBITDA recovery.
Via Stocktwits · February 25, 2026
The company’s annual report projected in detail how AI-driven investments broadened beyond an initial niche customer base, fueling capacity expansion across logic and memory manufacturers.
Via Stocktwits · February 25, 2026
10x Research also found that other companies linked to cryptocurrencies, such as miners and exchange operators, also have high short ratios.
Via Stocktwits · February 25, 2026
GLXY stock gained in pre-market trading on Wednesday after Citi said Galaxy Digital’s diversification is a double-edged sword in a note to investors.
Via Stocktwits · February 25, 2026

Co-CEO Doug Ostrover and Co-President Craig Packer made the acknowledgement during a call on Monday with thousands of financial advisors who distribute the company’s funds.
Via Stocktwits · February 25, 2026
First Solar’s full-year revenue came below Wall Street expectations and a quarterly profit miss has raised investor concerns regarding cost pressure due to tariffs.
Via Stocktwits · February 25, 2026
Retail traders have long been ‘bearish’ on DJT amid a sharp slide in the stock.
Via Stocktwits · February 25, 2026
The computers and printers company said profit would come at the lower-end of its previously issued FY26 guidance.
Via Stocktwits · February 25, 2026

Stocktwits data showed retail message volume around WULF’s stock jumped more than 270% over the past day, with sentiment shifting from ‘bearish’ to ‘bullish’ territory.
Via Stocktwits · February 25, 2026
Data from Stocktwits showed that retail sentiment on SPY and QQQ diverged.
Via Stocktwits · February 25, 2026
Joby Aviation stock gained enormously in 2025 but has tumbled since the beginning of the year on plans to raise capital in January.
Via Stocktwits · February 25, 2026
For Nvidia stock, earnings have historically triggered muted or negative reactions despite strong fundamentals.
Via Stocktwits · February 25, 2026
The company also plans to unveil its new flagship ES9 SUV around April 10, with pricing expected in late May and deliveries starting June 1.
Via Stocktwits · February 25, 2026
After the company’s stock rallied in January following Trump’s comments on lowering mortgage rates, investors have grown cautious about Rocket Companies' growth prospects amid AI disruption fears.
Via Stocktwits · February 25, 2026
The company guided for $900 million to $1 billion in 2026 revenue.
Via Stocktwits · February 25, 2026

The move comes after the SEC in January clarified that tokenized securities fall under existing federal laws regardless of being on-chain.
Via Stocktwits · February 25, 2026
Chardan cited operational efficiencies and expected margin lift as Lifileucel manufacturing is fully internalized.
Via Stocktwits · February 25, 2026
The company is heavily investing in scale AI for buyers and sellers on its platforms to drive more revenue growth while the bottom line remains squeezed.
Via Stocktwits · February 25, 2026
CEOs of Apple and major chip-makers like Nvidia were briefed by the CIA in 2023 on intelligence indicating China could move to take over Taiwan in 2027, according to the NYT.
Via Stocktwits · February 25, 2026
The overall cryptocurrency market rose 3.1% in the last 24 hours, climbing back above $2.3 trillion.
Via Stocktwits · February 25, 2026
Nvidia accounts for roughly 8% of the S&P 500, making its Q4 earnings a market-moving event.
Via Stocktwits · February 25, 2026
Zeta’s AI-powered growth continues to keep investors happy, as news of an AI disruption that could negatively impact them had put them on edge.
Via Stocktwits · February 24, 2026
Strong guidance and surging demand for high-protein, healthy meals lift Cava — but margin pressure and value-conscious consumers keep the battle tight.
Via Stocktwits · February 24, 2026
Investors will also focus on Nvidia’s earnings, amid closer scrutiny of large-cap technology valuations and rising concerns over hyperscalers’ capital spending on AI.
Via Stocktwits · February 24, 2026
The revision brought full-year output just below the roughly 18,000-unit guidance Lucid had set after cutting its target twice last year.
Via Stocktwits · February 24, 2026
“It's a bank, guys, and it has a federal charter. It's not going to get replaced by Claude or OpenAI,” Cramer said.
Via Stocktwits · February 24, 2026
UBS upgrades the stock while Evercore and Jefferies argue Claude’s COBOL tool is no threat to IBM’s mainframe moat.
Via Stocktwits · February 24, 2026
The power-chip maker reported fourth-quarter revenue above expectations and said it is in multiple discussions for new customer deals.
Via Stocktwits · February 24, 2026
Traders debated whether Trump could reference cancer priorities or FDA reform, with some betting a mention could spark another leg higher for IBRX.
Via Stocktwits · February 24, 2026
The company now sees FY26 adjusted core profit of $176 million to $184 million for FY26, in line with an analyst estimate of $182.70 million.
Via Stocktwits · February 24, 2026
It reported adjusted net income of $178 million, or $2.15 per diluted share beating analysts expected profit of $1.6 per share.
Via Stocktwits · February 24, 2026
According to a report from Reuters, Commerce Assistant Secretary for Export Enforcement David Peters said at a congressional hearing on Tuesday that as per his understanding, none of the chips had gone to China.
Via Stocktwits · February 24, 2026
Warner Bros. said that its board has not determined as to whether the revised PSKY proposal is superior to the merger with Netflix.
Via Stocktwits · February 24, 2026
Tradr 2X Long SNDK Daily ETF Becomes Fastest Growing ETF of the Past 12 Months
Via Stocktwits · February 24, 2026
The base version of the Cybertruck, called the Dual Motor AWD variant, starts at $59,990 now.
Via Stocktwits · February 24, 2026
Theriva Biologics licenses SYN-020 to Rasayana for $300k upfront and up to $38M in future milestones.
Via Stocktwits · February 24, 2026
Theriva Biologics to present VCN-01 Phase 1 and preclinical data for retinoblastoma at APAO 2026.
Via Stocktwits · February 24, 2026
Workday Inc. reported revenues of $2.53 billion, an increase of 14.5% from the same period last year, and marginally above Wall Street estimates of $2.52 billion, as per data from Fiscal.ai.
Via Stocktwits · February 24, 2026

The company reported a Q4 loss per share of $3.62, higher than an estimated loss of $2.63 per share, according to data from Fiscal AI.
Via Stocktwits · February 24, 2026
The company reported fourth quarter net income per diluted share of $4.84, which was well below analysts’ estimates of $5.24 per share, according to data from fiscal.ai.
Via Stocktwits · February 24, 2026
Shares of Novo Nordisk and Eli Lilly slipped in afternoon trade after the former announced a reduction in the list prices of its weight loss drugs, Ozempic and Wegovy.
Via Stocktwits · February 24, 2026
In a report from Business Insider, Freedom Capital Markets chief market strategist Jay Woods said that updates on tariff policy, and plans of military action against Iran could impact markets.
Via Stocktwits · February 24, 2026
The class action challenges DraftKings' advertised "$1,000 Deposit Bonus" promotion for new sportsbook customers in Massachusetts.
Via Stocktwits · February 24, 2026
Stripe has expressed preliminary interest in a potential acquisition of the digital payments pioneer or its assets, Bloomberg reported on Tuesday.
Via Stocktwits · February 24, 2026
According to a report from Bloomberg, which cited people familiar with the matter, the loan would help fund a cloud computing capacity buildout for Meta Platforms Inc.
Via Stocktwits · February 24, 2026
The company is expected to post a revenue of $95.6 million, more than twice what it reported in the same quarter last year.
Via Stocktwits · February 24, 2026
The outcome of the proceedings is inherently uncertain. No assurance can be given that PriceRunner will succeed on liability or quantum, the company said in a statement.
Via Stocktwits · February 24, 2026